Notably, for the first time, we also showed that DMT1 and TFR1 are both targets of YAP, clarifying a novel mechanism through which the LncRIM-NF2-DMT1/TFR1 axis ultimately promotes tumor progression by inducing changes in cellular iron levels. The gene discussed is YAP1; the disease is neoplasm.